Lung Cancer (PACIFIC-4 / RTOG-3515)

Study Information

Status: Active, Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

Greater Sacramento Valley

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of Durvalumab following stereotactic body radiation therapy (SBRT) for the treatment of Patients with Stage I/II Non Small Cell Lung Cancer (PACIFIC-4/RTOG-3515)

Principal Investigator

Christopher Jones, MD

Co-Investigator(s)

Charlotte D Kubicky, Radiation Oncologist, Carlin R Hauck, Radiation Oncologist, Anthony T Pu, Radiation Oncologist, Hubert Y Pan, Radiation Oncologist, Sivakumar Reddy, M.D., Vijay Suhag, M.D., Deepti Behl, MD

Funder

Astra Zeneca

Related Studies

SEER Lung Cancer

SEER-Lung: A Prospective Blood Sample Collection Study to Develop and Validate a Panel of Proteinbased Biomarkers in Patients with Pulmonary Nodules

Investigator: Tze-Ming Chen, M.D., FCCP

The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity

Using EHR from a large healthcare system in Northern CA, we will study the impact of smoking, comorbidities, race on COVID-19 infection and disease severity.

Investigator: Jiang Li, Ph.D., MPH

We've expanded your view